# Use of PET/MRI Tracer to Further Understanding of Prostate Cancer Development

> **NCT02106416** · NA · COMPLETED · sponsor: **NYU Langone Health** · enrollment: 21 (actual)

## Conditions studied

- Prostate Cancer
- Bladder Cancer

## Interventions

- **PROCEDURE:** PET/MRI

## Key facts

- **NCT ID:** NCT02106416
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2016-04
- **Final completion:** 2016-04
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2017-10-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02106416

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02106416, "Use of PET/MRI Tracer to Further Understanding of Prostate Cancer Development". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02106416. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*